COVID-19SARS-CoV-2Case fatality rateCardiovascular diseaseHeart failureMyocardial infarctionPurpose of review: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is identified from Wuhan, China, and has spread almost worldwide. Recently, the newly identified SARS-CoV-2 has been confirmed ...
It should also be noted that the rates of asymptomatic carriage are directly linked to the rate of infection where studies are performed. These data highlight the principle of early detection of pre-symptomatic patients and risk mitigation with COVID-19 in the context of cytotoxic and myelo...
As the use of this platform has increased with the rollout of the ChAdOx COVID-19 vaccine and potential future use of the vector, particularly for viruses and other pathogens endemic to the same areas i.e. Ebola, LASV and Malaria, vector-specific immunity and its potential role in vaccine...
The case fatality rate (CFR), i.e., the proportion of deaths from COVID-19 compared to the total number of diagnosed patients, is around 2.21%; while the estimated overall infection fatality rate (IFR), i.e., the proportion of deaths among all infected individuals including asymptomatic ...
In elderly patients, case fatality rate was up to 50% [36]. SARS-CoV-2 has a wider range of transmission than SARS-CoV or MERS-CoV, and infects a larger number of patients, but the ratio of critically ill COVID-19 patients is relatively lower. Epidemiological characteristics of more ...
Remdesivir GS-5734 Coronavirus COVID-19 SARS-CoV-2 Compassionate use 1. Introduction The first human coronaviruses (HCoVs) were identified in the 1960s [1], and for the majority of the past six decades, HCoVs have generally maintained a relatively innocuous reputation as a cause of the comm...
South Korea reported 1,709 more cases of COVID-19 as of midnight Thursday compared to 24 hours ago, raising the total number of infections to 257,110. Five more deaths were confirmed, leaving the death toll at 2,308. The total fatality rate stood at 0.90 percent. ...
The overall fatality rate of COVID-19 appears to be lower (about 2%) than that of SARS (estimated to be 10%) and Middle East Respiratory Syndrome (MERS) (estimated to be 37%).1Despite the lower fatality rate, the high infection rate had driven COVID-19 to more fatalities than the to...
Coronavirus COVID-19 SARS-CoV-2 N protein Antagonists Inhibitors 1. Introduction Human coronaviruses (HCoVs), including HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1 typically cause subclinical infections [1]. However, three novel coronaviruses (CoVs) with high mortality rates have emerged ...
The fatality rates of SARS-CoV, MERS-CoV and SARS-CoV-2 are 9.5%, 34.4%, and 2.3% respectively [6]. COVID-19 shows some particular pathogenic, epidemiological and clinical features which have are not completely understood to date as well as its wide and high transmission in the community...